British scientists claim to be for the first time growing human body parts in a laboratory at the University College London,which they say could soon make organ donation a thing of the past.
A team,led by Prof Alexander Seifalian of the varsitys Department of Nanotechnology and Regenerative Medicine,claims it is actually focussing on growing replacement organs and body parts to order,using a patients own cells. Because the organ is made from the patients own cells,the risk of rejection should,in theory,be eliminated.
This is a nose were growing for a patient next month. Its a world first. Nobody has ever grown a nose before, Prof Seifalian was quoted by the Daily Mail as saying as he plucked a Petri dish from the bench beside him.
Scientists say that when the the nose is transferred to the patient,it doesnt go directly onto the face but will be placed inside a balloon inserted beneath the skin on their arm. After four weeks,during which time skin and blood vessels can grow,the nose can be monitored,then it can be transplanted to the face,they say.
Team member Adelola Oseni added: Other groups have tried to tackle nose replacement with implants but weve found they dont last. They migrate,the shape of the nose changes. But our one will hold itself completely,as its an entire nose shape made out of polymer.
Looking like very thin Latex rubber,the polymer is made up of billions of molecules,each measuring just over one nanometre (a billionth of a metre),or 40,000 times smaller than the width of a human hair. Working at molecular level allows the material itself to be intricately detailed.
Inside this nanomaterial are thousands of small holes. Tissue grows into these and becomes part of it. It becomes the same as a nose and will even feel like one, Seifalian said.
Other parts in the making include the trachea windpipe to be used in the worlds first synthetic organ transplant,and an artery,say the scientists.
We are the first in the world working on this. We can make a metre every 20 seconds if we need to. However,the full success of these implants needs to be tested with a larger number of patients in clinical trials, said Seifalian.


